<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Because patients who undergo allogeneic hematopoietic cell transplantation (allo-HCT) remain in the vicinity of the transplant center for approximately 90 days posttransplantation, identifying prognostic factors to determine those at immediate higher risk of mortality is essential </plain></SENT>
<SENT sid="1" pm="."><plain>A <z:mpath ids='MPATH_458'>normal</z:mpath> serum albumin level generally denotes healthiness </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated the prognostic significance of day 90 <z:hpo ids='HP_0003073'>hypoalbuminemia</z:hpo> (and other clinical, pharmacologic, and laboratory variables) in 163 patients, median age 48 years (range, 19-69 years), who underwent allo-HCT for <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (n = 124) or <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (n = 39) </plain></SENT>
<SENT sid="3" pm="."><plain>Day 90 <z:hpo ids='HP_0003073'>hypoalbuminemia</z:hpo> (serum albumin &lt;3.0 g/dL) was associated with worse nonrelapse mortality (NRM) and poor overall survival (OS) </plain></SENT>
<SENT sid="4" pm="."><plain>The estimated 1- and 2-year cumulative incidence rates of NRM were 48% and 52%, respectively, and the corresponding OS rates were 7% and 3% </plain></SENT>
<SENT sid="5" pm="."><plain>Serum albumin level &lt;3.0 g/dL and Karnofsky score &lt;80 at day 90 were strong independent predictors of worse NRM and OS in multivariate analysis </plain></SENT>
<SENT sid="6" pm="."><plain>These results support day 90 <z:hpo ids='HP_0003073'>hypoalbuminemia</z:hpo> as an adverse prognostic marker for NRM and OS after allo-HCT for <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
</text></document>